Pomegranate (Punica Granatum)
Functional Foods in Health and Disease 2016; 6(12):769-787 Page 769 of 787 Research Article Open Access Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics Veljko Veljkovic1,2, Sanja Glisic2, Vladimir Perovic2, Nevena Veljkovic2, Garth L Nicolson3 1Biomed Protection, Galveston, TX, USA; 2Center for Multidisciplinary Research, University of Belgrade, Institute of Nuclear Sciences VINCA, P.O. Box 522, 11001 Belgrade, Serbia; 3Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Corresponding author: Garth L Nicolson, PhD, MD (H), Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Submission Date: October 3, 2016, Accepted Date: December 18, 2016, Publication Date: December 30, 2016 Citation: Veljkovic V.V., Glisic S., Perovic V., Veljkovic N., Nicolson G.L.. Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics. Functional Foods in Health and Disease 2016; 6(12):769-787 ABSTRACT Background: Numerous in vitro and in vivo studies, in addition to clinical data, demonstrate that pomegranate juice can prevent or slow-down the progression of some types of cancers. Despite the well-documented effect of pomegranate ingredients on neoplastic changes, the molecular mechanism(s) underlying this phenomenon remains elusive. Methods: For the study of pomegranate ingredients the electron-ion interaction potential (EIIP) and the average quasi valence number (AQVN) were used. These molecular descriptors can be used to describe the long-range intermolecular interactions in biological systems and can identify substances with strong electron-acceptor properties.
[Show full text]